Conclusions
urinary incontinence symptoms, pelvic floor muscle exercise, urinary incontinence
SECONDARY, URINARY INCONTINENCE
In summary, although we did not find a significant difference in urinary symptoms between the treatment group and the placebo group at six weeks at the proposed large effect size (Cohen’s d = 1.06), there was a significant improvement in the treatment group in all examined primary and secondary outcomes compared to baseline. However, no difference was found in the control group. In our trial, short-term (six weeks) pelvic floor muscle exercise did not improve significantly urinary incontinence symptoms. This finding is not a surprise since most guidelines recommend twelve weeks of PFMT for achieving improvement in SUI symptoms. However, we are the first to report that when daily PFMT was augmented by a specially formulated supplement, the urinary incontinence symptoms, biomechanical integrity of the pelvic floor, and pelvic floor muscle strength significantly improved in a relatively short time period. Based on our findings, we suspect that the daily supplementation with Incoxil®, while pelvic floor training was ongoing, resulted in faster improvement in pelvic floor muscle strength and biomechanical integrity, which indeed led to better urinary control after only six weeks of treatment. Our findings are preliminary, and additional studies with a larger sample size are needed to verify our hypothesis.